Ann: Appendix 4C & Quarterly Activity Report - 30 June 2024, page-6

This company will always be remembered for one thing, old Judith taking it down the rabbit hole from the get-go on the OTC side of things… The reality is, they should’ve gone the drug path in the US market and the whole thing five years later would’ve been a different story. Fools Gold as they say when you have idiots with nothing more than JJ behind their name running something that they have no business being involved in from the get-go. Always remember, Judith took this company down a path and a rabbit hole that she never should’ve. last one to leave turn the lights off. Cheers.